TC-325 hemostatic powder versus current standard of care in managing malignant GI bleeding: a pilot randomized clinical trial

TC-325, an endoscopic hemostatic powder, exhibits possible benefits in patients with malignant gastrointestinal (GI) bleeding. The aim is to assess feasibility and determine estimates of efficacy of TC-325 compared with standard of care (SOC) in terms of initial hemostasis and recurrent bleeding rates in comparable groups of patients with malignant GI bleeding.

Source: Gastrointestinal Endoscopy - August 18, 2019 Category: Gastroenterology Authors: Yen-I. Chen, Jonathan Wyse, Yidan Lu, Myriam Martel, Alan N. Barkun Source Type: research